14.90
price up icon5.37%   0.76
after-market Dopo l'orario di chiusura: 14.68 -0.22 -1.48%
loading
Precedente Chiudi:
$14.14
Aprire:
$13.47
Volume 24 ore:
3.09M
Relative Volume:
2.31
Capitalizzazione di mercato:
$690.53M
Reddito:
$217.11M
Utile/perdita netta:
$-651.19M
Rapporto P/E:
-1.147
EPS:
-12.99
Flusso di cassa netto:
$-387.26M
1 W Prestazione:
+52.66%
1M Prestazione:
+62.13%
6M Prestazione:
+16.22%
1 anno Prestazione:
+22.94%
Intervallo 1D:
Value
$13.36
$15.48
Intervallo di 1 settimana:
Value
$9.78
$15.48
Portata 52W:
Value
$5.00
$16.85

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name
Nome
Ginkgo Bioworks Holdings Inc
Name
Telefono
(877) 442-5362
Name
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Name
Dipendente
834
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-08
Name
Ultimi documenti SEC
Name
DNA's Discussions on Twitter

Confronta DNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
DNA
Ginkgo Bioworks Holdings Inc
14.90 827.64M 217.11M -651.19M -387.26M -12.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-15 Downgrade BTIG Research Neutral → Sell
2024-05-10 Downgrade William Blair Mkt Perform → Underperform
2023-11-14 Downgrade Raymond James Outperform → Mkt Perform
2023-11-09 Downgrade BTIG Research Buy → Neutral
2023-06-02 Downgrade Goldman Neutral → Sell
2023-05-11 Downgrade William Blair Outperform → Mkt Perform
2022-11-29 Iniziato Berenberg Buy
2022-10-04 Iniziato Morgan Stanley Equal-Weight
2022-05-18 Downgrade BofA Securities Neutral → Underperform
2022-03-02 Ripresa Cowen Outperform
2022-02-23 Iniziato Goldman Neutral
2022-02-01 Iniziato BofA Securities Neutral
2022-01-28 Iniziato BofA Securities Buy
2022-01-07 Iniziato BTIG Research Buy
2021-11-29 Iniziato Jefferies Buy
2021-10-13 Iniziato Raymond James Outperform
2021-10-12 Iniziato William Blair Outperform
2021-09-20 Iniziato HSBC Securities Buy
Mostra tutto

Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie

pulisher
Jul 24, 2025

How high can Ginkgo Bioworks Holdings Inc. stock price go in 2025Exceptional financial outcomes - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Ginkgo Bioworks Holdings Inc. stockConsistently high yield - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is Ginkgo Bioworks Holdings Inc. a good long term investmentSuperior returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Ginkgo Bioworks Holdings Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Ginkgo Bioworks Holdings Inc. stock pricePhenomenal capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why - MSN

Jul 21, 2025
pulisher
Jul 17, 2025

Ginkgo Bioworks launches cost-effective ADME profiling service By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors - MarketScreener

Jul 17, 2025
pulisher
Jul 17, 2025

Ginkgo Disrupts Drug Discovery Market with US-Based ADME Service Matching Chinese Prices - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know - sharewise.com

Jul 16, 2025
pulisher
Jul 16, 2025

Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Share Price Not Quite Adding Up - 富途牛牛

Jul 16, 2025
pulisher
Jul 11, 2025

When the Price of (DNA) Talks, People Listen - news.stocktradersdaily.com

Jul 11, 2025
pulisher
Jul 10, 2025

Ginkgo Bioworks Holdings (DNA) Shares Fall Despite Market Gains - AInvest

Jul 10, 2025
pulisher
Jul 03, 2025

Ginkgo Bioworks (DNA) Shares Soar 5.29% on Q2 Earnings - AInvest

Jul 03, 2025
pulisher
Jul 01, 2025

Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? - MSN

Jul 01, 2025
pulisher
Jul 01, 2025

Ginkgo Bioworks Surges 18.9%, Can Further Upside Be Expected? - AInvest

Jul 01, 2025
pulisher
Jun 30, 2025

(DNA) On The My Stocks Page - news.stocktradersdaily.com

Jun 30, 2025
pulisher
Jun 29, 2025

Ginkgo Bioworks Holdings, Inc.(NYSE: DNA) added to Russell 2500 Index - MarketScreener

Jun 29, 2025
pulisher
Jun 26, 2025

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know - MSN

Jun 26, 2025
pulisher
Jun 25, 2025

Ginkgo Bioworks: Is the Biotech's Undervalued Platform Poised for Scalable Growth? - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Ginkgo Bioworks stock rises on Hugging Face collaboration for AI drug development - Investing.com Canada

Jun 24, 2025
pulisher
Jun 18, 2025

Lobbying Update: $10,000 of GINKGO BIOWORKS lobbying was just disclosed - Nasdaq

Jun 18, 2025
pulisher
Jun 13, 2025

Ginkgo Bioworks Holds Annual Shareholder Meeting, Elects Directors - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io

Jun 12, 2025
pulisher
Jun 11, 2025

Ginkgo Bioworks (DNA) Sees 5.4% Increase in Stock Price | DNA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 09, 2025

Where are the Opportunities in (DNA) - news.stocktradersdaily.com

Jun 09, 2025
pulisher
Jun 06, 2025

Ginkgo Bioworks: Hedge Funds Pull Back and Other Important Updates - TradingView

Jun 06, 2025
pulisher
Jun 06, 2025

Squarepoint Ops LLC Has $417,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

From Promise to Peril: The Downfall of Ginkgo Bioworks - TradingView

Jun 04, 2025

Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):